Good Shad
Known title: VP, Sales for North AmericaCIK: 0002047216
Associated companies
Transaction History
| ICCM | ▲ Buy | Grant | 131,483 | $0 | 8/14/2026 | View on chart |
| ICCM | ▲ Buy | Grant | 131,483 | $0 | 8/14/2026 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
ICCM Adds Legacy Health Site for Prosense Cryoablation Study
IceCure Medical announced it has added Legacy Health in Portland, Oregon, as a new U.S. clinical site for its post‑marketing ChoICE study of Prosense Cryoablation. The expansion increases the number of patients enrolled in the low‑risk breast cancer trial, which could provide more robust safety and efficacy data. The study is part of the company’s effort to support the market launch of its cryoablation technology. The addition is a routine development in the company’s clinical program.
ICCM Adds Legacy Health Site for Prosense Cryoablation Study. IceCure Medical announced it has added Legacy Health in Portland, Oregon, as a new U.S. clinical site for its post‑marketing ChoICE study of Prosense Cryoablation. The expansion increases the number of patients enrolled in the low‑risk breast cancer trial, which could provide more robust safety and efficacy data. The study is part of the company’s effort to support the market launch of its cryoablation technology. The addition is a routine development in the company’s clinical program.